文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

COVID-19相关ARDS接受ECMO治疗幸存者一年身心健康评估

One-Year Mental and Physical Health Assessment in Survivors after Extracorporeal Membrane Oxygenation for COVID-19-related Acute Respiratory Distress Syndrome.
PubMed 文献 · Am J Respir Crit Care Med · 2023-01-01
一句话结论COVID-19相关ARDS接受ECMO治疗的幸存者1年时肺功能部分恢复,但焦虑、抑郁、PTSD风险及工作能力仍显著受损。

该多中心前瞻性研究纳入2020年3月至6月法国7个ICU中因COVID-19相关ARDS接受ECMO并存活出院的患者。80例符合条件者中62例入组,ECMO和侵入性机械通气时间分别为18(11-25)天和36(27-62)天。1年时全部存活,但仅19/50(38%)重返工作、13/42(31%)性欲恢复正常;6个月肺功能几乎正常,但DLCO在12个月时仍受损。1年时19/43(44%)有显著焦虑、18/43(42%)有抑郁症状、21/50(42%)有创伤后应激障碍风险;与非COVID-19的ECMO患者相比,心理健康、角色情感和角色躯体维度受损最重。

要点

  • 1年时全部存活,但仅19/50(38%)重返工作,13/42(31%)性欲恢复正常。
  • 6个月肺功能几乎正常,但DLCO在12个月时仍受损。
  • 1年时19/43(44%)有显著焦虑,18/43(42%)有抑郁症状,21/50(42%)有PTSD风险。
  • 与非COVID-19的ECMO患者相比,心理健康、角色情感和角色躯体维度受损最重。
  • 作者认为,身心健康不良可能更多与COVID-19本身而非ECMO相关,但尚需确认。

适用人群与场景

  • 2020年3月至6月法国7个ICU中因COVID-19相关ARDS接受ECMO并存活出院的患者。
  • 80例符合条件患者中62例入组。

研究设计与关键结果

  • 多中心前瞻性研究:80例符合条件患者中62例入组,来自法国7个ICU。
  • ECMO持续时间18(11-25)天,侵入性机械通气持续时间36(27-62)天。
  • 1年时全部存活,但仅19/50(38%)重返工作,13/42(31%)性欲恢复正常。
  • 6个月肺功能几乎正常,但DLCO在12个月时仍受损。
  • 1年时19/43(44%)有显著焦虑,18/43(42%)有抑郁症状,21/50(42%)有PTSD风险。
  • 与非COVID-19的ECMO患者相比,心理健康、角色情感和角色躯体维度受损最重。

证据类型、等级与局限

  • 证据类型:多中心前瞻性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,身心健康不良可能更多与COVID-19本身而非ECMO相关,但尚需确认。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Rationale: Long-term outcomes of patients with coronavirus disease (COVID-19)-related acute respiratory distress syndrome treated with extracorporeal membrane oxygenation (ECMO) are unknown. Objectives: To assess physical examination, pulmonary function tests, anxiety, depression, post-traumatic stress disorder and quality of life at 6 and 12 months after ECMO onset. Methods: Multicenter, prospective study in patients who received ECMO for COVID-19 acute respiratory distress syndrome from March to June 2020 and survived hospital discharge. Measurements and Main Results: Of 80 eligible patients, 62 were enrolled in seven French ICUs. ECMO and invasive mechanical ventilation duration were 18 (11-25) and 36 (27-62) days, respectively. All were alive, but only 19/50 (38%) returned to work and 13/42 (31%) had recovered a normal sex drive at 1 year. Pulmonary function tests were almost normal at 6 months, except for DlCO, which was still impaired at 12 months. Mental health, role-emotional, and role-physical were the most impaired domain compared with patients receiving ECMO who did not have COVID-19. One year after ICU admission, 19/43 (44%) patients had significant anxiety, 18/43 (42%) had depression symptoms, and 21/50 (42%) were at risk for post-traumatic stress disorders. Conclusions: Despite the partial recovery of the lung function tests at 1 year, the physical and psychological function of this population remains impaired. Based on the comparison with long-term follow-up of patients receiving ECMO who did not have COVID-19, poor mental and physical health may be more related to COVID-19 than to ECMO in itself, although this needs confirmation.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Chommeloux J, Valentin S, Winiszewski H, et al. One-Year Mental and Physical Health Assessment in Survivors after Extracorporeal Membrane Oxygenation for COVID-19-related Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2023. PMID: 36150112. doi:10.1164/rccm.202206-1145OC

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。